MME and type 1 diabetes mellitus: An increased level of Aβ in the temporal lobe was observed in a monkey model of type 1 diabetes mellitus, with the greatest increase observed in the hippocampus; in addition, these parts of the brain demonstrated decreased levels of neprilysin (NEP), the Aβ-degrading enzyme, at the protein and mRNA levels [116].